John Van Johnston has a strong background in the pharmaceutical industry, with a focus on access, reimbursement, patient, and provider support. John Van has held various director-level positions at companies such as Acadia Pharmaceuticals Inc., Recordati Rare Diseases Inc., and Takeda. John joined Takeda through the acquisition of Shire and has experience in business development, sales training, and product management. John holds a BS in Finance and Psychology from San Diego State University and completed a Clerkship in Rheumatology at Stanford University.
December, 2022 - present